In conclusion, the current study reveals a novel role for PIP5K1A in suppressing ferroptosis by competitively binding to KEAP1 and subsequent stabilizing NRF2 protein, ultimately protecting HCC cells form sorafenib‐induced ferroptosis. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.